{"ORPHApacket":[{"ORPHApacketID":"485358","date":"2019-12-06 05:48:19","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"485358","Name":[{"lang":"en","label":"Propylthiouracil embryofetopathy"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_485358","DisorderType":[{"Name":[{"lang":"en","label":"Malformation syndrome"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377789"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Teratogenic Pierre Robin syndrome"}],"ORPHA":"138059","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_138059"},{"Name":[{"lang":"en","label":"Toxic or drug-related embryofetopathy"}],"ORPHA":"251529","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_251529"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"Propylthiouracil embryofetopathy is a rare teratologic disease characterized by variable congenital anomalies resulting from maternal treatment and prenatal exposure to propylthiouracil. Anomalies frequently encountered include ear malformations (e.g. accessory auricle, preauricular sinus\/fistula\/cyst), urinary system malformations (e.g. isolated unilateral kidney, congenital hydronephrosis), gastrointestinal anomalies (e.g. congenital bands with intestinal malrotation) and cardiac defects (e.g. situs inversus dextrocardia, cardiac outflow tract defects)."}],"SynonymList":[{"count":"3","Synonym":[{"lang":"en","label":"PTU embryofetopathy"},{"lang":"en","label":"PTU embryopathy"},{"lang":"en","label":"Propylthiouracil embryopathy"}]}]}]}